Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido®or Reandron®) in men with congenital hypogonadotrophic hypogonadism-Reference-Cited by-同舟云学术

Unexpectedly prolonged washout period of exogenous testosterone after discontinuation of intramuscular testosterone undecanoate depot injection (Nebido®or Reandron®) in men with congenital hypogonadotrophic hypogonadism

Published:2016-02-10 Issue:6 Volume:84 Page:947-950
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Gan Earn H.¹²,Bouloux Pierre-Marc³,Quinton Richard¹²

Affiliation:

1. Endocrine Unit; Newcastle-upon-Tyne Hospitals; Newcastle-upon-Tyne UK

2. Endocrine Research Unit; Institute of Genetic Medicine; University of Newcastle-upon-Tyne; Newcastle-upon-Tyne UK

3. Centre for Neuroendocrinology (Royal Free Campus); University College London; London UK

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference9 articles.

1. Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study;Eckardstein;Journal of Andrology,2002

2. Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism;Schubert;Journal of Clinical Endocrinology & Metabolism,2004

3. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1,438 men;Zitzmann;Journal of Sexual Medicine,2013

4. Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis;Liu;Lancet,2006

5. Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc A phase III, multi-center, open label, uncontrolled trial to investigate the efficacy and safety of MK-8962 (corifollitropin alfa) in combination with human Chorionic Gonadotropin (hCG) in inducing increased testicular volume and spermatogenesis in adult men with hypogonadotropic hypogonadism who remain azoospermic when treated with hCG alone ClinicalTrials.gov http://clinicaltrials.gov/show/NCT01709331

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections;European Journal of Endocrinology;2022-03-01

2. Cryptozoospermia after treatment with clomiphene citrate following long-term use of intramuscular testosterone undecanoate depot injection (Nebido®);Hormone Molecular Biology and Clinical Investigation;2019-03-14

3. Clinical Management of Congenital Hypogonadotropic Hypogonadism;Endocrine Reviews;2019-01-29

4. Fertility induction in hypogonadotropic hypogonadal men;Clinical Endocrinology;2018-10-09